首页> 美国卫生研究院文献>Designed Monomers and Polymers >Luminescent property and application values of a new Cd(II) compound in tuberculosis treatment and clinical nursing
【2h】

Luminescent property and application values of a new Cd(II) compound in tuberculosis treatment and clinical nursing

机译:结核病治疗和临床护理的新CD(II)化合物的发光性能和应用值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Through the reaction between HTrz and Cd(NO3)2 · 4H2O, a new Cd(II) compound of [Cd(Trz) 2] n (1, HTrz = 1,2,4-triazole) can be obtained, which has been studied with diffraction analysis by single crystal X-ray as well as powder X-ray diffraction. The structure of 1 can be stable up to 265°C, and the solid samples of 1 emit intense blue luminescence at room temperature. Along with the evaluation of tuberculosis treatment and clinical nursing, related mechanism was also studied here. Firstly, ELISA assay was conducted and the IL-10 and IL-18 released into the alveolar lavage fluid was determined. Apart from this, the real-time RT-PCR was used to reflect surviving gene’s relative expression of Mycobacterium tuberculosis after compound treatment.
机译:通过HTRZ和Cd(NO3)2·4H2O之间的反应,可以获得[CD(TRZ)2] N(1,HTRZ = 1,2,4-三唑)的新CD(II)化合物,其用单晶X射线以及粉末X射线衍射进行衍射分析研究。 1的结构可以稳定高达265℃,并且1的固体样品在室温下发射强烈的蓝色发光。随着结核病治疗和临床护理的评估,这里还研究了相关机制。首先,进行ELISA测定,并测定释放到肺泡灌洗液中的IL-10和IL-18。除此之外,实时RT-PCR用于反映复合处理后分枝杆菌结核病的幸存基因的相对表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号